TMCI:NASDAQ
Treace Medical Concepts, Inc
$4.31
arrow_downward
-0.92%(-0.040) 1D
$4.31
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 20, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
$4.31
High
$4.43
Low
$4.17
Mkt. cap
282.56M
Avg. vol.
288.65K
Volume
232.75K
52-wk high
$5.44
52-wk low
$1.17
EPS
-$0.86
Beta
1.59
Shares outstanding
65.56M
No. of employees
450
Open
$4.31
High
$4.43
Low
$4.17
Mkt. cap
282.56M
Avg. vol.
288.65K
Volume
232.75K
52-wk high
$5.44
52-wk low
$1.17
EPS
-$0.86
Beta
1.59
Shares outstanding
65.56M
No. of employees
450
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Top Movers: Today's Biggest Gainers and Losers
WHEC.com
·
4 minutes ago
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year as rout in tech stocks tanks the market
marketscreener.com
·
26 minutes ago
S&P 500, Dow Slide Into Correction Territory as Investors Seek Treasury Cover Amid Big-Tech Plunge
finance.biggo.com
·
16 minutes ago
Goldman Sachs: Year-End S&P 500 Rally Could Lose Half Its Punch as Fear Runs Hot
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc